Can pegylated interferon improve the outcome of polycythemia vera patients?

Can pegylated interferon improve the outcome of polycythemia vera patients?

Abstract Pegylated interferon (peg-IFN) was proven by phase II trials to be effective in polycythemia vera (PV); however, it is not clear whether it could improve patient outcome compared to hydroxyurea (HU). Here, we present an observational study on 65 PV patients aged 65 years or younger, who rec...

Full description

Bibliographic Details
Main Authors: Elena Crisà, Marco Cerrano, Eloise Beggiato, Giulia Benevolo, Giuseppe Lanzarone, Paola Maria Manzini, Alessandra Borchiellini, Ludovica Riera, Mario Boccadoro, Dario Ferrero
Format: Article
Language:English
Published: BMC 2017-01-01
Series:Journal of Hematology & Oncology
Subjects:
Pegylated interferon
Polycythemia vera
JAK2 allele burden
Hydroxyurea
Online Access:http://link.springer.com/article/10.1186/s13045-017-0395-1

Internet

http://link.springer.com/article/10.1186/s13045-017-0395-1

Similar Items